Experimental Therapeutics – Preclinical 2018
DOI: 10.1136/jnnp-2018-ehdn.239
|View full text |Cite
|
Sign up to set email alerts
|

I03 Mutant HTT MRNA as therapeutic target in allele-selective cag repeat-directed rnai approach and putative pathogenic agent in hd

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles